Location History:
- Munich, DE (2008)
- Somerville, MA (US) (2008 - 2011)
Company Filing History:
Years Active: 2008-2011
Title: The Innovative Contributions of Jonathan Rothblatt
Introduction
Jonathan Rothblatt is a notable inventor based in Somerville, MA (US). He has made significant contributions to the field of biotechnology, holding a total of 3 patents. His work focuses on processes that enhance our understanding of critical biological mechanisms.
Latest Patents
One of Rothblatt's latest patents is titled "Method of screening for gamma-secretase activity." This invention relates to an improved process for determining γ-secretase activity and for detecting γ-secretase, a subunit protein of γ-secretase, or a γ-secretase-like proteinase. The patent outlines processes for identifying γ-secretase or cDNA that codes for γ-secretase, as well as substances that can inhibit the activity of γ-secretase. Another significant patent involves the identification and use of the DAF-2/IR responsive sod-3 promoter. This invention describes transgenic constructs containing the sod-3 reporter gene, which are useful for identifying genes or compounds that can modulate the DAF-2/IR-akt pathway.
Career Highlights
Jonathan Rothblatt is currently employed at Sanofi-Aventis Deutschland GmbH, where he continues to contribute to innovative research and development in biotechnology. His work has implications for understanding diseases and developing therapeutic strategies.
Collaborations
Throughout his career, Rothblatt has collaborated with esteemed colleagues such as Edmund Hoppe and Ulrike Siebers. These collaborations have further enriched his research and expanded the impact of his inventions.
Conclusion
Jonathan Rothblatt's innovative work in biotechnology, particularly in the area of γ-secretase activity and the DAF-2/IR pathway, showcases his commitment to advancing scientific knowledge. His contributions are vital to the ongoing research in this field.